Catechol-O-methyltransferase gene expression in stress-induced and non-stress induced schizophrenia
- PMID: 31568068
- DOI: 10.1097/YPG.0000000000000243
Catechol-O-methyltransferase gene expression in stress-induced and non-stress induced schizophrenia
Abstract
Introduction: As schizophrenia is a complex mental disorder and the outcome of gene-gene-environmental interactions, there are different possible pathophysiological mechanisms in different schizophrenia subtypes corresponding to various risk factors. This study was aimed at examining the impact of one of the most likely interactions, that is, 'dopamine and stress', in schizophrenia pathogenesis.
Methods: Here, we investigated the interaction between 'war-related psychological trauma' without brain trauma and catechol-O-methyltransferase gene. Using real-time PCR analysis we measured catechol-O-methyltransferase gene expression level in the blood cells of 66 male subjects in four groups, namely veteran schizophrenia patients as 'stress-exposed schizophrenia' (S-schizophrenia), their healthy brothers as 'their genetically closest relatives' (S-siblings), schizophrenia patients without any history of significant stress as 'non-stress-exposed schizophrenia' (NoS-schizophrenia), and the control group. The results were analyzed by Relative Expression Software Tool 2009 software.
Results: The catechol-O-methyltransferase gene expression was not significantly different between the S-schizophrenia and NoS-schizophrenia groups. However, compared to the control group, the catechol-O-methyltransferase expression was significantly decreased in three groups of S-schizophrenia, their healthy siblings, and NoS-schizophrenia patients.
Conclusion: This data supports that reduced blood catechol-O-methyltransferase expression, which may be associated with higher dopamine level, is involved both in stress-induced and non-stress-induced schizophrenia.
Similar articles
-
Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.Psychol Med. 2013 Feb;43(2):279-92. doi: 10.1017/S0033291712001134. Epub 2012 May 23. Psychol Med. 2013. PMID: 22617427
-
Dopaminergic pathway gene polymorphisms and genetic susceptibility to schizophrenia among north Indians.Neuropsychobiology. 2010;61(2):64-70. doi: 10.1159/000265131. Epub 2009 Dec 12. Neuropsychobiology. 2010. PMID: 20016224
-
Catechol-o-methyltransferase polymorphism and susceptibility to major depressive disorder modulates psychological stress response.Psychiatr Genet. 2007 Jun;17(3):183-93. doi: 10.1097/YPG.0b013e32808374df. Psychiatr Genet. 2007. PMID: 17417063
-
Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions.Harv Rev Psychiatry. 2007 Sep-Oct;15(5):233-44. doi: 10.1080/10673220701650409. Harv Rev Psychiatry. 2007. PMID: 17924258 Review.
-
Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.CNS Drugs. 2007;21(7):535-57. doi: 10.2165/00023210-200721070-00002. CNS Drugs. 2007. PMID: 17579498 Review.
Cited by
-
Effect of electroacupuncture on global cerebral ischemia-reperfusion injury in rats: A urine proteome analysis.Brain Behav. 2024 Jan;14(1):e3382. doi: 10.1002/brb3.3382. Brain Behav. 2024. PMID: 38376040 Free PMC article.
-
Identification of important gene signatures in schizophrenia through feature fusion and genetic algorithm.Mamm Genome. 2024 Jun;35(2):241-255. doi: 10.1007/s00335-024-10034-7. Epub 2024 Mar 21. Mamm Genome. 2024. PMID: 38512459
References
-
- Abdolmaleky HM, Thiagalingam S, Wilcox M. Genetics and epigenetics in major psychiatric disorders. Am J Pharmacogenomics. 2005; 5:149–160
-
- Abdolmaleky HM, Cheng K.-H, Faraone SV, Wilcox M, Glatt SJ, Gao F, et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet. 2006; 15:3132–3145
-
- Abdolmaleky HM, Smith CL, Zhou JR, Thiagalingam S. Fatemi SH. Epigenetic modulation of reelin function in schizophrenia and bipolar disorder. Reelin Glycoprotein. 2008, New York: Springer
-
- Abdolmaleky HM, Yaqubi S, Papageorgis P, Lambert AW, Ozturk S, Sivaraman V, et al. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophr Res. 2011; 129:183–190
-
- Beaulieu-Boire I, Lang AE. Behavioral effects of levodopa. Move Disord. 2015; 30:90–102
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous